| Profile | GDS5420 / 229359_at |
| Title | Psoriasis response to brodalumab: dose response and time course |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM1296094 | A_lesional_pre-dose | 379.21 | 63 |
| GSM1296119 | B_lesional_pre-dose | 293.86 | 59 |
| GSM1296076 | C_lesional_pre-dose | 279.48 | 59 |
| GSM1296092 | D_lesional_pre-dose | 332.09 | 62 |
| GSM1296103 | E_lesional_pre-dose | 266.71 | 57 |
| GSM1296078 | F_lesional_pre-dose | 278.46 | 59 |
| GSM1296107 | G_lesional_pre-dose | 261.49 | 56 |
| GSM1296109 | H_lesional_pre-dose | 270.25 | 56 |
| GSM1296080 | I_lesional_pre-dose | 236.62 | 56 |
| GSM1296090 | J_lesional_pre-dose | 288.99 | 59 |
| GSM1296074 | K_lesional_pre-dose | 492.8 | 69 |
| GSM1296111 | L_lesional_pre-dose | 248.83 | 55 |
| GSM1296099 | M_lesional_pre-dose | 277.68 | 57 |
| GSM1296086 | O_lesional_pre-dose | 292.63 | 60 |
| GSM1296117 | P_lesional_pre-dose | 231.02 | 54 |
| GSM1296113 | Q_lesional_pre-dose | 330.4 | 60 |
| GSM1296096 | R_lesional_pre-dose | 187.88 | 52 |
| GSM1296105 | S_lesional_pre-dose | 293.3 | 58 |
| GSM1296098 | T_lesional_pre-dose | 238.53 | 55 |
| GSM1296101 | U_lesional_pre-dose | 290.43 | 58 |
| GSM1296121 | V_lesional_pre-dose | 274.83 | 57 |
| GSM1296088 | W_lesional_pre-dose | 343.52 | 62 |
| GSM1296082 | X_lesional_pre-dose | 296.85 | 60 |
| GSM1296115 | Y_lesional_pre-dose | 242.07 | 55 |
| GSM1296084 | Z_lesional_pre-dose | 361.22 | 62 |
| GSM1296072 | B_lesional_day8 | 222.72 | 53 |
| GSM1296069 | L_lesional_day8 | 209.69 | 51 |
| GSM1296071 | P_lesional_day8 | 252.73 | 54 |
| GSM1296070 | Y_lesional_day8 | 206.6 | 51 |
| GSM1296073 | V_lesional_day8 | 295.38 | 59 |
| GSM1296034 | A_lesional_day15 | 300.97 | 58 |
| GSM1296041 | G_lesional_day15 | 234.64 | 55 |
| GSM1296035 | R_lesional_day15 | 297.76 | 59 |
| GSM1296038 | U_lesional_day15 | 262.83 | 57 |
| GSM1296047 | B_lesional_day15 | 225.22 | 53 |
| GSM1296039 | E_lesional_day15 | 195.99 | 52 |
| GSM1296042 | H_lesional_day15 | 243.09 | 55 |
| GSM1296043 | L_lesional_day15 | 180.7 | 49 |
| GSM1296037 | M_lesional_day15 | 200.71 | 52 |
| GSM1296046 | P_lesional_day15 | 245.84 | 54 |
| GSM1296044 | Q_lesional_day15 | 293.03 | 57 |
| GSM1296045 | Y_lesional_day15 | 232.53 | 53 |
| GSM1296025 | C_lesional_day15 | 342.88 | 62 |
| GSM1296033 | D_lesional_day15 | 352.59 | 62 |
| GSM1296027 | I_lesional_day15 | 365.41 | 63 |
| GSM1296032 | J_lesional_day15 | 256.15 | 56 |
| GSM1296024 | K_lesional_day15 | 331.66 | 61 |
| GSM1296031 | W_lesional_day15 | 283.6 | 57 |
| GSM1296028 | X_lesional_day15 | 242.38 | 56 |
| GSM1296029 | Z_lesional_day15 | 270.05 | 57 |
| GSM1296026 | F_lesional_day15 | 240.36 | 56 |
| GSM1296030 | O_lesional_day15 | 475.65 | 67 |
| GSM1296040 | S_lesional_day15 | 229.82 | 54 |
| GSM1296036 | T_lesional_day15 | 342.89 | 60 |
| GSM1296048 | V_lesional_day15 | 282.96 | 58 |
| GSM1296059 | A_lesional_day43 | 273.82 | 58 |
| GSM1296066 | G_lesional_day43 | 303 | 59 |
| GSM1296060 | R_lesional_day43 | 215.79 | 53 |
| GSM1296063 | U_lesional_day43 | 294.51 | 59 |
| GSM1296064 | E_lesional_day43 | 233.63 | 56 |
| GSM1296067 | H_lesional_day43 | 262.94 | 55 |
| GSM1296062 | M_lesional_day43 | 213.05 | 53 |
| GSM1296068 | Q_lesional_day43 | 278.28 | 56 |
| GSM1296050 | C_lesional_day43 | 162.81 | 49 |
| GSM1296057 | D_lesional_day43 | 288.03 | 58 |
| GSM1296052 | I_lesional_day43 | 333.93 | 61 |
| GSM1296054 | J_lesional_day43 | 349.8 | 61 |
| GSM1296049 | K_lesional_day43 | 272.14 | 58 |
| GSM1296055 | W_lesional_day43 | 198.87 | 51 |
| GSM1296053 | X_lesional_day43 | 300.73 | 59 |
| GSM1296058 | Z_lesional_day43 | 232.87 | 55 |
| GSM1296051 | F_lesional_day43 | 277.66 | 59 |
| GSM1296056 | O_lesional_day43 | 249.02 | 57 |
| GSM1296065 | S_lesional_day43 | 290.56 | 58 |
| GSM1296061 | T_lesional_day43 | 290.33 | 58 |
| GSM1296095 | A_non-lesional_pre-dose | 320.81 | 61 |
| GSM1296120 | B_non-lesional_pre-dose | 261.2 | 56 |
| GSM1296077 | C_non-lesional_pre-dose | 286.72 | 59 |
| GSM1296093 | D_non-lesional_pre-dose | 245.12 | 55 |
| GSM1296104 | E_non-lesional_pre-dose | 173.76 | 50 |
| GSM1296079 | F_non-lesional_pre-dose | 206.04 | 54 |
| GSM1296108 | G_non-lesional_pre-dose | 209.21 | 52 |
| GSM1296110 | H_non-lesional_pre-dose | 254.2 | 55 |
| GSM1296081 | I_non-lesional_pre-dose | 169.1 | 51 |
| GSM1296091 | J_non-lesional_pre-dose | 305.62 | 60 |
| GSM1296075 | K_non-lesional_pre-dose | 403.7 | 65 |
| GSM1296112 | L_non-lesional_pre-dose | 217.92 | 52 |
| GSM1296100 | M_non-lesional_pre-dose | 163.1 | 48 |
| GSM1296087 | O_non-lesional_pre-dose | 374.56 | 64 |
| GSM1296118 | P_non-lesional_pre-dose | 230.36 | 53 |
| GSM1296114 | Q_non-lesional_pre-dose | 293.11 | 58 |
| GSM1296097 | R_non-lesional_pre-dose | 162.67 | 49 |
| GSM1296106 | S_non-lesional_pre-dose | 239.02 | 54 |
| GSM1296102 | U_non-lesional_pre-dose | 318.19 | 59 |
| GSM1296122 | V_non-lesional_pre-dose | 193.12 | 51 |
| GSM1296089 | W_non-lesional_pre-dose | 263.56 | 56 |
| GSM1296083 | X_non-lesional_pre-dose | 176.79 | 50 |
| GSM1296116 | Y_non-lesional_pre-dose | 199.46 | 50 |
| GSM1296085 | Z_non-lesional_pre-dose | 246.47 | 56 |